Heron Therapeutics, Inc. · NASDAQ:HRTX

Collard Craig A exercised options for 13,797 Heron Therapeutics, Inc. shares (Form 4)

Traded Jul 19, 2026 · Filed Jul 20, 2026

On Jul 19, 2026, Collard Craig A (Director, Chief Executive Officer) exercised options for 13,797 Heron Therapeutics, Inc. shares, leaving 771,682 shares. Filed Jul 20, 2026 (Form 4).

Options exercised
13,797 shares
Holding after
771,682 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 19, 2026Common StockOption exercise13,797771,682Direct

Source

View original at SEC

Related